Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Benjian Gao, Jia Luo, Ying Liu, Song Su, Shaozhi Fu, Xiaoli Yang & Bo Li. (2021) Intratumoral Administration of Thermosensitive Hydrogel Co-Loaded with Norcantharidin Nanoparticles and Doxorubicin for the Treatment of Hepatocellular Carcinoma. International Journal of Nanomedicine 16, pages 4073-4085.
Read now
Read now
Zhenghai Zhang, Lei Yang, Jian Hou, Xiaojing Xia, Jing Wang, Qing Ning & Shulong Jiang. (2018) Promising positive liver targeting delivery system based on arabinogalactan-anchored polymeric micelles of norcantharidin. Artificial Cells, Nanomedicine, and Biotechnology 46:sup3, pages 630-640.
Read now
Read now
Min-Chen Liu, Lin Liu, Xia-Rong Wang, Wu-Ping Shuai, Ying Hu, Min Han & Jian-Qing Gao. (2016) Folate receptor-targeted liposomes loaded with a diacid metabolite of norcantharidin enhance antitumor potency for H22 hepatocellular carcinoma both in vitro and in vivo. International Journal of Nanomedicine 11, pages 1395-1412.
Read now
Read now
Mingna Li, Xiaofen Xu, Fei Lu & Shengrong Guo. (2014) Primary in vitro and in vivo evaluation of norcantharidin-chitosan/poly (vinyl alcohol) for cancer treatment. Drug Delivery 21:4, pages 293-301.
Read now
Read now
Xia Lin, Bo Zhang, Keru Zhang, Yu Zhang, Juan Wang, Na Qi, Shenshen Yang, Haibing He & Xing Tang. (2012) Preclinical evaluations of norcantharidin-loaded intravenous lipid microspheres with low toxicity. Expert Opinion on Drug Delivery 9:12, pages 1449-1462.
Read now
Read now
Articles from other publishers (32)
Bing-Tao Zhai, Jing Sun, Ya-Jun Shi, Xiao-Fei Zhang, Jun-Bo Zou, Jiang-Xue Cheng, Yu Fan, Dong-Yan Guo & Huan Tian. (2022) Review targeted drug delivery systems for norcantharidin in cancer therapy. Journal of Nanobiotechnology 20:1.
Crossref
Crossref
Saman Sargazi, Mohammad Reza Hajinezhad, Mahmood Barani, Abbas Rahdar, Sheida Shahraki, Pouya Karimi, Magali Cucchiarini, Mehrdad Khatami & Sadanand Pandey. (2021) Synthesis, characterization, toxicity and morphology assessments of newly prepared microemulsion systems for delivery of valproic acid. Journal of Molecular Liquids 338, pages 116625.
Crossref
Crossref
Ioanna Theochari, Aristotelis Xenakis & Vassiliki Papadimitriou. 2020. Smart Nanocontainers. Smart Nanocontainers
315
341
.
Zhe Ma, Bing Zhang, Yuqi Fan, Meng Wang, Dereje Kebebe, Jiawei Li & Zhidong Liu. (2019) Traditional Chinese medicine combined with hepatic targeted drug delivery systems: A new strategy for the treatment of liver diseases. Biomedicine & Pharmacotherapy 117, pages 109128.
Crossref
Crossref
Shulong Jiang, Mengying Li, Ying Hu, Zhenhai Zhang & Huixia Lv. (2018) Multifunctional self-assembled micelles of galactosamine-hyaluronic acid-vitamin E succinate for targeting delivery of norcantharidin to hepatic carcinoma. Carbohydrate Polymers 197, pages 194-203.
Crossref
Crossref
Xiaolin Liu, Xiaoguang Tao, Qi Zheng, Hang Xu, Yu Zhang, Tian Lei, Tian Yin, Haibing He & Xing Tang. (2017) Development and validation of an LC-ESI-MS/MS approach to determine a highly hydrophobic drug, norcantharidin palmitate, and apply to a preliminary pharmacokinetic study in rats. Biomedical Chromatography 31:12, pages e4010.
Crossref
Crossref
Sanju Singh, Poonam Parashar, Jovita Kanoujia, Indu Singh, Sudipta Saha & Shubhini A. Saraf. (2017) Transdermal potential and anti-gout efficacy of Febuxostat from niosomal gel. Journal of Drug Delivery Science and Technology 39, pages 348-361.
Crossref
Crossref
Hiroyuki OhshimaSoumik Bardhan, Kaushik Kundu, Gulmi Chakraborty, Bidyut K. Paul, Satya P. Moulik & Swapan K. Saha. 2016. Encyclopedia of Biocolloid and Biointerface Science 2V Set. Encyclopedia of Biocolloid and Biointerface Science 2V Set
122
144
.
Ming-Che Chang, Jin-Yi Wu, Hui-Fen Liao, Yu-Jen Chen & Cheng-Deng Kuo. (2016) Comparative assessment of therapeutic safety of norcantharidin, N-farnesyloxy-norcantharimide, and N-farnesyl-norcantharimide against Jurkat T cells relative to human normal lymphoblast. Medicine 95:31, pages e4467.
Crossref
Crossref
Cheng Peng, Zequn Li, Zhengchuan Niu, Wei Niu, Zongquan Xu, Huijie Gao, Weibo Niu, JiaYong Wang, Zhaobin He, Chao Gao, Pengfei Lin, Michael Agrez, Zongli Zhang & Jun Niu. (2016) Norcantharidin Suppresses Colon Cancer Cell Epithelial-Mesenchymal Transition by Inhibiting the αvβ6-ERK-Ets1 Signaling Pathway. Scientific Reports 6:1.
Crossref
Crossref
Ming-Che Chang, Jin-Yi Wu, Hui-Fen Liao, Yu-Jen Chen & Cheng-Deng Kuo. (2015) N-Farnesyloxy-norcantharimide inhibits progression of human leukemic Jurkat T cells through regulation of mitogen-activated protein kinase and interleukin-2 production. Anti-Cancer Drugs 26:10, pages 1034-1042.
Crossref
Crossref
Gurpreet Kaur, S.K. Mehta, Sandeep Kumar, Gaurav Bhanjana & Neeraj Dilbaghi. (2015) Coencapsulation of Hydrophobic and Hydrophilic Antituberculosis Drugs in Synergistic Brij 96 Microemulsions: A Biophysical Characterization. Journal of Pharmaceutical Sciences 104:7, pages 2203-2212.
Crossref
Crossref
Ming-Che Chang, En-Tung Tsai, Jin-Yi Wu, Hui-Fen Liao, Yu-Jen Chen & Cheng-Deng Kuo. (2015) N-Farnesyloxy-norcantharimide and N-farnesyl-norcantharimide inhibit the progression of leukemia and increase survival days in a syngeneic mouse leukemia model. Anti-Cancer Drugs 26:5, pages 508-517.
Crossref
Crossref
Neha Jindal & S.K. Mehta. (2015) Nevirapine loaded Poloxamer 407/Pluronic P123 mixed micelles: Optimization of formulation and in vitro evaluation. Colloids and Surfaces B: Biointerfaces 129, pages 100-106.
Crossref
Crossref
S. K. Mehta & Neha Jindal. (2014) Tyloxapol Niosomes as Prospective Drug Delivery Module for Antiretroviral Drug Nevirapine. AAPS PharmSciTech 16:1, pages 67-75.
Crossref
Crossref
Maung Win, Paul Lang, Manu Vashishtha & Dinesh Shah. 2014. Surfactant Science and Technology. Surfactant Science and Technology
377
398
.
S.K. Mehta & Neha Jindal. (2013) Mixed micelles of Lecithin–Tyloxapol as pharmaceutical nanocarriers for anti-tubercular drug delivery. Colloids and Surfaces B: Biointerfaces 110, pages 419-425.
Crossref
Crossref
X.Q. Wang & Q. Zhang. 2013. Drug Delivery Strategies for Poorly Water-Soluble Drugs. Drug Delivery Strategies for Poorly Water-Soluble Drugs
287
323
.
S.K. Mehta & Neha Jindal. (2013) Formulation of Tyloxapol niosomes for encapsulation, stabilization and dissolution of anti-tubercular drugs. Colloids and Surfaces B: Biointerfaces 101, pages 434-441.
Crossref
Crossref
Min Guan, Yi Zhou, Qiao-Ling Zhu, Yang Liu, Yong-Yan Bei, Xue-Nong Zhang & Qiang Zhang. (2012) N-trimethyl chitosan nanoparticle-encapsulated lactosyl-norcantharidin for liver cancer therapy with high targeting efficacy. Nanomedicine: Nanotechnology, Biology and Medicine 8:7, pages 1172-1181.
Crossref
Crossref
Kedong Lu, Mingzhuo Cao, Weiwei Mao, Xuanrong Sun, Jianbin Tang, Youqing Shen & Meihua Sui. (2012) Targeted acid-labile conjugates of norcantharidin for cancer chemotherapy. Journal of Materials Chemistry 22:31, pages 15804.
Crossref
Crossref
Flora Cimmino, Maria Nunzia Scoppettuolo, Marianeve Carotenuto, Pasqualino De Antonellis, Valeria Di Dato, Gennaro De Vita & Massimo Zollo. (2011) Norcantharidin impairs medulloblastoma growth by inhibition of Wnt/β-catenin signaling. Journal of Neuro-Oncology 106:1, pages 59-70.
Crossref
Crossref
Ranajay Saha, Pramod Kumar Verma, Rajib Kumar Mitra & Samir Kumar Pal. (2011) Structural and dynamical characterization of unilamellar AOT vesicles in aqueous solutions and their efficacy as potential drug delivery vehicle. Colloids and Surfaces B: Biointerfaces 88:1, pages 345-353.
Crossref
Crossref
Surinder K. Mehta, Neha Jindal & Gurpreet Kaur. (2011) Quantitative investigation, stability and in vitro release studies of anti-TB drugs in Triton niosomes. Colloids and Surfaces B: Biointerfaces 87:1, pages 173-179.
Crossref
Crossref
Qin Wang, Liang Zhang, Wei Hu, Zhan-Hong Hu, Yong-Yan Bei, Jing-Yu Xu, Wen-Juan Wang, Xue-Nong Zhang & Qiang Zhang. (2010) Norcantharidin-associated galactosylated chitosan nanoparticles for hepatocyte-targeted delivery. Nanomedicine: Nanotechnology, Biology and Medicine 6:2, pages 371-381.
Crossref
Crossref
S.K. Mehta, Gurpreet Kaur & K.K. Bhasin. (2010) Entrapment of multiple anti‐Tb drugs in microemulsion system: Quantitative analysis, stability, and in vitro release studies. Journal of Pharmaceutical Sciences 99:4, pages 1896-1911.
Crossref
Crossref
S. K. Mehta, Gurpreet Kaur & K. K. Bhasin. (2010) Tween-Embedded Microemulsions—Physicochemical and Spectroscopic Analysis for Antitubercular Drugs. AAPS PharmSciTech 11:1, pages 143-153.
Crossref
Crossref
Cheng Peng, Xiangqun Liu, Enyu Liu, Kesen Xu, Weibo Niu, Rong Chen, Jiayong Wang, Zhaoyang Zhang, Pengfei Lin, Jian Wang, Michael Agrez & Jun Niu. (2009) Norcantharidin induces HT‐29 colon cancer cell apoptosis through the αvβ6–extracellular signal‐related kinase signaling pathway. Cancer Science 100:12, pages 2302-2308.
Crossref
Crossref
Yu-Jen Chen, Cheng-Deng Kuo, Yin-Meng Tsai, Chih-Chia Yu, Guang-Sheng Wang & Hui-Fen Liao. (2008) Norcantharidin induces anoikis through Jun-N-terminal kinase activation in CT26 colorectal cancer cells. Anti-Cancer Drugs 19:1, pages 55-64.
Crossref
Crossref
S. K. Mehta, Gurpreet Kaur & K. K. Bhasin. (2007) Incorporation of Antitubercular Drug Isoniazid in Pharmaceutically Accepted Microemulsion: Effect on Microstructure and Physical Parameters. Pharmaceutical Research 25:1, pages 227-236.
Crossref
Crossref
Syamasri Gupta & S.P. Moulik. (2008) Biocompatible Microemulsions and Their Prospective Uses in Drug Delivery. Journal of Pharmaceutical Sciences 97:1, pages 22-45.
Crossref
Crossref
S.K. Mehta, Gurpreet Kaur & K.K. Bhasin. (2007) Analysis of Tween based microemulsion in the presence of TB drug rifampicin. Colloids and Surfaces B: Biointerfaces 60:1, pages 95-104.
Crossref
Crossref